Citizens analyst Jonathan Wolleben reiterated a Market Perform rating on Sionna Therapeutics (NASDAQ: SION).The analyst commented, "New analysis of the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments